Almost 30% of the patients in a pilot program for those with psoriasis that was devised by researchers from the Perelman School of Medicine at the University of Pennsylvania were identified as having undiagnosed, elevated risk for cardiovascular disease. Those patients were then able to be given more individualized care over the next year, but all participants received extra care and guidance.
Leave A Comment